IDiyas

For the Inventor, By the Inventor

Allschwil, Switzerland

Hans Michael Bürger

USPTO Granted Patents = 8 


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:

goldMedal8 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2005-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 9573928 - N-phenyl-2-pyrimidine-amine derivatives (2017-02-21),
2. 8513256 - Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide (2013-08-20),
3. 7825247 - N-phenyl-2-pyrimidine-amine derivatives (2010-11-02),
4. 7816359 - N-phenyl-2-pyrimidine-amine derivatives (2010-10-19),
5. 7579467 - [object Object] (2009-08-25),
6. 7544799 - Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use (2009-06-09),
7. 7456283 - N-phenyl-2-pyrimidine-amine derivatives (2008-11-25),
8. 6894051 - Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use (2005-05-17),

Title: The Innovative Contributions of Hans Michael Bürger

Introduction

Hans Michael Bürger is a notable inventor based in Allschwil, Switzerland. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents. His work focuses on the development of novel compounds that have potential applications in medicine.

Latest Patents

Among his latest patents is the invention of N-phenyl-2-pyrimidine-amine derivatives. This invention relates to novel amides and a process for preparing these amides. Another significant patent involves salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide. This invention pertains to acid addition salts of a specific compound, which includes various salt forms such as tartrate, hydrochloride, citrate, and more.

Career Highlights

Hans Michael Bürger is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative drug development and contribute to advancements in medical science.

Collaborations

Throughout his career, Hans has collaborated with several talented individuals, including Olivier Loiseleur and Daniel Kaufmann. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise.

Conclusion

Hans Michael Bürger's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of new medical treatments and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…